Raymond James & Associates AIMMUNE THERAPEUTICS INC Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 04, 2020	SELL	N/A	-28,349 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	N/A	16,727 Added 143.93%	28,349 $474,000
Q1 2020 Apr 21, 2020	SELL	N/A	-16,237 Reduced 58.28%	11,622 $168,000
Q4 2019 Feb 12, 2020	BUY	N/A	2,274 Added 8.89%	27,859 $932,000
Q3 2019 Nov 07, 2019	SELL	N/A	-15,980 Reduced 38.45%	25,585 $536,000
Q2 2019 Aug 06, 2019	SELL	N/A	-12,399 Reduced 22.98%	41,565 $865,000
Q1 2019 May 06, 2019	BUY	N/A	7,581 Added 16.34%	53,964 $1.21 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-4,959 Reduced 9.66%	46,383 $1.11 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-2,766 Reduced 5.11%	51,342 $1.4 Million
Q2 2018 Aug 14, 2018	BUY	N/A	5,612 Added 11.57%	54,108 $1.46 Million
Q1 2018 May 14, 2018	BUY	N/A	23,759 Added 96.05%	48,496 $1.54 Million
Q4 2017 Feb 14, 2018	BUY	N/A	1,669 Added 7.24%	24,737 $936,000
Q3 2017 Nov 13, 2017	BUY	N/A	51 Added 0.22%	23,068 $572,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,017	23,017 $473,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.